Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study
Please note: this is a legacy publication from CPEC (formely PSSRU at LSE).Pharmacoeconomics 26 4 341-358
Available online: 22 September 2012